Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Finished Goods: 2014-2017

Historic Finished Goods for Vanda Pharmaceuticals (VNDA) over the last 4 years, with Dec 2017 value amounting to $760,000.

  • Vanda Pharmaceuticals' Finished Goods rose 31.98% to $1.0 million in Q1 2018 from the same period last year, while for Mar 2018 it was $1.0 million, marking a year-over-year increase of 31.98%. This contributed to the annual value of $760,000 for FY2017, which is 0.26% down from last year.
  • As of FY2017, Vanda Pharmaceuticals' Finished Goods stood at $760,000, which was down 0.26% from $762,000 recorded in FY2016.
  • Vanda Pharmaceuticals' Finished Goods' 5-year high stood at $3.4 million during FY2014, with a 5-year trough of $760,000 in FY2017.
  • For the 3-year period, Vanda Pharmaceuticals' Finished Goods averaged around $938,667, with its median value being $762,000 (2016).
  • Data for Vanda Pharmaceuticals' Finished Goods shows a maximum YoY crashed of 61.87% (in 2015) over the last 5 years.
  • Vanda Pharmaceuticals' Finished Goods (Yearly) stood at $3.4 million in 2014, then tumbled by 61.87% to $1.3 million in 2015, then plummeted by 41.11% to $762,000 in 2016, then fell by 0.26% to $760,000 in 2017.